Log in to save to my catalogue

Correction: Ibrutinib, a Bruton's tyrosine kinase inhibitor, exhibits antitumoral activity and induc...

Correction: Ibrutinib, a Bruton's tyrosine kinase inhibitor, exhibits antitumoral activity and induc...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_8dfe304061694e5781eac70edf0fd2c1

Correction: Ibrutinib, a Bruton's tyrosine kinase inhibitor, exhibits antitumoral activity and induces autophagy in glioblastoma

About this item

Full title

Correction: Ibrutinib, a Bruton's tyrosine kinase inhibitor, exhibits antitumoral activity and induces autophagy in glioblastoma

Publisher

England: BioMed Central Ltd

Journal title

Journal of experimental & clinical cancer research, 2025-02, Vol.44 (1), p.46-5

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

Subjects

Subjects and topics

More information

Alternative Titles

Full title

Correction: Ibrutinib, a Bruton's tyrosine kinase inhibitor, exhibits antitumoral activity and induces autophagy in glioblastoma

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_8dfe304061694e5781eac70edf0fd2c1

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_8dfe304061694e5781eac70edf0fd2c1

Other Identifiers

ISSN

0392-9078,1756-9966

E-ISSN

1756-9966

DOI

10.1186/s13046-025-03304-y

How to access this item